Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering

被引:5
作者
Yousefi-Ahmadipour, Aliakbar [1 ,2 ,3 ]
Asadi, Fatemeh [3 ]
Pirsadeghi, Ali [3 ]
Nazeri, Niloofar [4 ]
Vahidi, Reza [5 ]
Abazari, Mohammad Foad [6 ]
Afgar, Ali [5 ]
Mirzaei-Parsa, Mohamad Javad [7 ,8 ]
机构
[1] Rafsanjan Univ Med Sci, Fac Paramed, Dept Lab Sci, Rafsanjan, Iran
[2] Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Immunol Infect Dis Res Ctr, Rafsanjan, Iran
[3] Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Mol Med Res Ctr, Rafsanjan, Iran
[4] Qazvin Univ Med Sci, Res Inst Prevent Non Commun Dis, Qazvin, Iran
[5] Kerman Univ Med Sci, Res Ctr Hydatid Dis Iran, Kerman, Iran
[6] Univ Tehran Med Sci, Res Ctr Clin Virol, Tehran, Iran
[7] Kerman Univ Med Sci, Cell Therapy & Regenerat Med Comprehens Ctr, Kerman, Iran
[8] Kerman Univ Med Sci, Fac Allied Med Sci, Dept Med Nanotechnol, Med Univ Campus,Haft Bagh Highway, Kerman, Iran
关键词
Cardiovascular diseases; Stem cells; Vascular regeneration; Nanofibrous scaffolds; Tissue engineering; CARDIOSPHERE-DERIVED CELLS; ACUTE MYOCARDIAL-INFARCTION; CARDIAC PROGENITOR CELLS; LEFT-VENTRICULAR FUNCTION; ISCHEMIC-HEART-DISEASE; BONE-MARROW-CELLS; VASCULAR GRAFT; CARDIOMYOCYTE APOPTOSIS; REGENERATIVE CELLS; INTRAMYOCARDIAL TRANSPLANTATION;
D O I
10.1007/s40883-021-00230-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Regenerative medicine is an emerging technology in medical sciences that aims to use its two main components, cell therapy and tissue engineering, to overcome untreatable diseases. Despite considerable advances in medicine, cardiovascular diseases (CVDs) are the number one cause of heart failure and death worldwide. To overcome this problem, cell therapy and tissue engineering alone or in combination with each other can be a promising therapeutic approach for CVDs. Cell therapy, especially stem cell therapy, is being developed as an attractive therapeutic platform for treating heart-associated diseases. There are different sources of stem cells with varying potencies that utilize each of them and are associated with a variety of advantages and disadvantages. The purpose of cardiac tissue engineering is to replace or repair injured cardiac muscle and vasculature in the heart. In this study, we focus on the current state of preclinical and clinical data regarding cell therapy with pluripotent stem cells, multipotent stem cells, and progenitor cells as well as cell-free-based therapy with extracellular vesicles (EVs) such as exosomes. Another major focus has been on the cardiovascular tissue engineering using biodegradable natural/synthetic nanofibers made by electrospinning technique. Lay Summary Because cardiovascular diseases (CVDs) are the main cause of death worldwide, the need to identify effective treatment strategies for this group of diseases is inevitable. Regenerative medicine, as an emerging and promising technology, is applying stem cell therapy and tissue engineering to overcome various problems. To outline advances of regenerative medicine for treatment of CVDs, here, we focus on the current preclinical and clinical knowledge regarding the cell (pluripotent/multipotent stem cells and progenitor cells)-based and cell-free (using extracellular vesicles) therapies. Furthermore, we address the role of biodegradable natural/synthetic electrospun nanofibers in cardiovascular tissue engineering.
引用
收藏
页码:248 / 268
页数:21
相关论文
共 50 条
[41]   Electrospun PHBV/collagen composite nanofibrous scaffolds for tissue engineering [J].
Meng, Wan ;
Kim, Se-Yong ;
Yuan, Jiang ;
Kim, Jung Chul ;
Kwon, Oh Hyeong ;
Kawazoe, Naoki ;
Chen, Guoping ;
Ito, Yoshihiro ;
Kang, Inn-Kyu .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2007, 18 (01) :81-94
[42]   Recent Advances in Electrospun Nanofibrous Scaffolds for Cardiac Tissue Engineering [J].
Zhao, Guoxu ;
Zhang, Xiaohui ;
Lu, Tian Jian ;
Xu, Feng .
ADVANCED FUNCTIONAL MATERIALS, 2015, 25 (36) :5726-5738
[43]   New directions in nanofibrous scaffolds for soft tissue engineering and regeneration [J].
Baker, Brendon M. ;
Handorf, Andrew M. ;
Ionescu, Lara C. ;
Li, Wan-Ju ;
Mauck, Robert L. .
EXPERT REVIEW OF MEDICAL DEVICES, 2009, 6 (05) :515-532
[44]   Electrospun Nanofibrous Polycaprolactone Scaffolds for Tissue Engineering of Annulus Fibrosus [J].
Koepsell, Laura ;
Zhang, Lifeng ;
Neufeld, Daniel ;
Fong, Hao ;
Deng, Ying .
MACROMOLECULAR BIOSCIENCE, 2011, 11 (03) :391-399
[45]   Decellularized Extracellular Matrix Scaffolds for Cardiovascular Tissue Engineering: Current Techniques and Challenges [J].
Barbulescu, Greta Ionela ;
Bojin, Florina Maria ;
Ordodi, Valentin Laurentiu ;
Goje, Iacob Daniel ;
Barbulescu, Andreea Severina ;
Paunescu, Virgil .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[46]   Engineering controllable anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal tissue engineering [J].
Li, Wan-Ju ;
Mauck, Robert L. ;
Cooper, James A. ;
Yuan, Xiaoning ;
Tuan, Rocky S. .
JOURNAL OF BIOMECHANICS, 2007, 40 (08) :1686-1693
[47]   Current status of tissue engineering in urology [J].
Wood, Dan ;
Southgate, Jennifer .
CURRENT OPINION IN UROLOGY, 2008, 18 (06) :564-569
[48]   The Current Status of Engineering Myocardial Tissue [J].
Runqian Sui ;
Xiaobo Liao ;
Xinmin Zhou ;
Qi Tan .
Stem Cell Reviews and Reports, 2011, 7 :172-180
[49]   Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives [J].
Topoliova, Katarina ;
Harsanyi, Stefan ;
Danisovic, Lubos ;
Ziaran, Stanislav .
MEDICINA-LITHUANIA, 2023, 59 (08)
[50]   Current Research Progress in Stem Cell Therapy and Tissue Engineering Using Decellularized Materials [J].
Oak, Anjali ;
Singh, Swati ;
Khan, Asim Mustafa ;
Pachore, Prateek J. .
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (50B) :329-346